EMERGING RISK IN MEDICAL MARIJUANA. Anthony E. Abeln, Esq. Noel B. Dumas, Esq.

Similar documents
States with Authority to Require Nonresident Pharmacies to Report to PMP

Medical Marijuana and Student Health. New England College Health Association Gordon H. Smith, Esq. October 30, 2014

Maine s Medical Marijuana Law. 40 th Annual ASMAC Fall Conference Ritz Carlton Lake Tahoe October 26, 2014

Understanding Maine s Medical Marijuana Law

Medical Marijuana Responsible for Traffic Fatalities Alfred Crancer, B.S., M.A.; Phillip Drum, Pharm.D.

2012 Medicaid and Partnership Chart

Medical Advisory Board. reviews medical issues for licensure regarding individual drivers. medical conditions. not specified. reporting encouraged,

Smoke and Mirrors: Navigating Medical Marijuana in the Workplace

Pennsylvania s Medical Marijuana Act. William Roark, Esq. HRMM&L

Diane E. Hoffmann, J.D., M.S. University of Maryland School of Law

The Marijuana Law Trend and Resulting Impact on Healthcare Providers

ACEP National H1N1 Preparedness Survey Results

Prevalence of Self-Reported Obesity Among U.S. Adults by State and Territory. Definitions Obesity: Body Mass Index (BMI) of 30 or higher.

Prescription Drug Monitoring Program (PDMP) Delaware. Information contained in this presentation is accurate as of November 2017

ARIZONA MEDICAL MARIJUANA PROGRAM. Tina Wesoloskie, MPA Office of Medical Marijuana Card Registry Arizona Department of Health Services

Average Number Citations per Recertification Survey

THE STATE OF THE STATES-A REPORT ON MEDICAL CANNABIS PROGRAMS MID YEAR MEETING AND SCIENTIFIC SEMINAR APRIL 13, 2018 NASHVILLE, TENNESSEE DEBBY MIRAN

If you suspect Fido's owner is diverting prescription pain meds meant for the pet, checking your state's drug monitoring database may not help

Responses to a 2017 Survey on State Policies Regarding Community Health Workers: Home Visiting to Improve the Home Environment

Case 8:14-cv DKC Document 2-4 Filed 11/17/14 Page 1 of 17. Exhibit 3

2018 HPV Legislative Report Card

Instant Drug Testing State Law Guide

In New York State. Highly Worth It OR Not??? Medical Marijuana. The Truths 3/29/2018. True or False???

2011 Jackson Lewis LLP. Prop 203 Passes by Thread

Workplace Issues Associated with Legalized Marijuana. James B. Yates, Esq., SHRM-SCP, SPHR

Prop 203 Passes by Thread

Peer Specialist Workforce. State-by-state information on key indicators, and links to each state s peer certification program web site.

Medical Marijuana Compliance. Neil Alexander and Sarah Watt Littler Mendelson P.C. May 9, 2017

Per Se BLOOD ALCOHOL CONCENTRATION AND MOTOR VEHICLE SAFETY

National Deaf Center on Postsecondary Outcomes. Data Interpretation Guide for State Reports: FAQ

Department of Public Safety

State, District, or Territory Criteria for Mandatory Enrol ment or Query of PDMP

Research Protocol for Medical Marijuana Dispensaries. Prepared by Legal Science, LLC

Re: Implementation of the Federal Tamper-Resistant Prescription Pad Mandate

Navigating Marijuana Law in the Workplace

Hepatitis C: The State of Medicaid Access. Preliminary Findings: National Summary Report

MAKING WAVES WITH STATE WATER POLICIES. Washington State Department of Health

Obesity Trends:

Opioid Deaths Quadruple Since 1999

Hawai i to Zero. Timothy McCormick Harm Reduction Services Branch Hawai i Department of Health. January 16, 2018

Public Health Federal Funding Request to Address the Opioid Epidemic

Medical marijuana vs. workplace policy

Medical Marijuana

Contents. Introduction. Acknowledgments. 1 Assisted Reproduction and the Diversity of the Modern Family 1. 2 Intrauterine Insemination 31.

Marijuana in the Workplace: The 411 on 420

Overview of the States Pesticide Registration Process AAPCO Laboratory Committee

Shannon Whitman Program Administrator Advancing Use of the MN PMP

Using Policy, Programs, and Partnerships to Stamp Out Breast and Cervical Cancers

Medical Marijuana Legalization Summit 2017

ROAD SAFETY MONITOR. ALCOHOL-IMPAIRED DRIVING IN THE UNITED STATES Results from the 2017 TIRF USA Road Safety Monitor

A Legal Look at Medical Marijuana. John J. Clifford, Esq. Clifford and Kenny, LLP 171 Rockland Street Hanover, MA 02339

Percent of U.S. State Populations Covered by 100% Smokefree Air Laws April 1, 2018

Peer Specialist Workforce. State-by-state information on key indicators, and links to each state s peer certification program web site.

Autism and Transition to Adulthood. Lorri Unumb, Esq. Vice President State Government Affairs Autism Speaks

ADVERTISING - CALIFORNIA

Analysis of State Medicaid Agency Performance in Relation to Incentivizing the Provision of H1N1 Immunizations to Eligible Populations

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

AN ECONOMIC IMPACT REPORT (EIR) ON THE MEDICAL CANNABIS INDUSTRY IN THE STATE OF NEVADA

Alcohol Safety. After reading this chapter, you will be able to:

Medical Marijuana: Is Green & Leafy Really Good for You? Objectives 2/14/2015. Do you live in a state where medical Marijuana is legal?

Recommendations for Re-Occupancy of Buildings Previously Used to Manufacture Methamphetamine

Georgina Peacock, MD, MPH

NM Coalition of Sexual Assault Programs, Inc.

City of Coral Gables Planning and Zoning Staff Recommendation

Youth and Adult Marijuana Use

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

SUMMARY OF SYNTHETIC CANNABINOID BILLS

AUL s 2014 Life List

Southwestern Conference on Medicine Presented by: Karen Wright RN BSN ARM CPHRM MICA Risk Management Services

PETITION FOR DUAL MEMBERSHIP

MARIJUANA IN THE PUBLIC WORKPLACE PHILIP A. TOOMEY

The Chiropractic Pediatric CE Credit Program with Emphasis on Autism

The Cannabis model in Canada and the USA. Dr Mark A Ware MD MRCP MSc McGill University Montreal, Quebec, Canada

V. OTHER WOMEN S HEALTH-RELATED SERVICES

Forensic Patients in State Hospitals:

Seeing through the Smoke: Preparing Your Workplace for Legalized Marijuana. October 23, 2018

Insight. Marijuana Legalization Efforts Enjoy Success, Demonstrating Major Shift in Approach to Drug Regulation and Use NOVEMBER 9, 2016

Dental Hygiene Participation in Regulation

THE STATE OF THE MEDICAL MARIJUANA MARKETS 2011

Cirrhosis and Liver Cancer Mortality in the United States : An Observational Study Supplementary Material

EMG Laws by State. needle EMGs and NCSs can be found in its position statement Who is Qualified to Practice EDX Medicine.

-Type of immunity that is more permanent (WBC can Remember)

The Rural Health Workforce. Policy Brief Series. Data and Issues for Policymakers in: Washington Wyoming Alaska Montana Idaho

It's tick time again! Recognizing black-legged (deer ticks) and measuring the spread of Lyme disease

From heroin to medical marijuana: what districts need to know Megan Greulich, Staff Attorney Hot Topics in School Law October 5, 2016

Medical Marijuana In the Workplace

Medical Marijuana In the Workplace

April 25, Edward Donnell Ivy, MD, MPH

Addressing Substance Abuse To Improve Well-Being in Child Welfare Systems Current Trends, Continuing Challenges

An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth

NM Coalition of Sexual Assault Programs, Inc.

September 20, Thomas Scully Administrator Centers for Medicare and Medicaid Services 200 Independence Avenue SW Washington, DC 20201

Proposed Prop 64 Changes. SHRM Law Day Prop 64, California Marijuana Legalization Initiative aka Adult Use of Marijuana Act.

STATE RANKINGS REPORT NOVEMBER mississippi tobacco data

Product Liability Update

Research Memo. 4. What are the sanctions for DUI accidents resulting in serious injury and/or death?

NCQA did not add new measures to Accreditation 2017 scoring.

Methamphetamines: A National and State Crisis. Research Brief. Prepared by

LEGAL ASPECTS of MEDICAL MARIJUANA Florida Nurse Practitioner Network Annual Conference September 17, 2018

IV. REPRODUCTIVE HEALTH SERVICES

Transcription:

EMERGING RISK IN MEDICAL MARIJUANA Anthony E. Abeln, Esq. Noel B. Dumas, Esq.

Legalized Medical Marijuana 28 States/Districts Have Legalized Medicinal Use of Marijuana In One Form Or Another Alabama Alaska Arizona California Colorado Connecticut District of Columbia Delaware Florida Hawaii Illinois Iowa Maine Maryland Massachusetts Michigan Minnesota Mississippi Montana Nevada New Hampshire New Jersey New Mexico Oregon Rhode Island Utah Vermont Washington

In Most States, Structure Of Marijuana System Is Created By Statute/Regulation. Although States Differ To Some Degree, There Are Two Main Structures: Cultivation Who And How Marijuana Is Grown And Processed Distribution Who And How Marijuana Is Sold To Patients

Distribution System All States Are Different And There Are Varying Degrees Of The Extent Of The Regulations. Some States Have Chosen to Be Heavily Regulated And Specific In Their Requirements. Connecticut s Marijuana Regulation Is 76 Pages Long. New Jersey s Marijuana Regulation Is 14 Pages Long. But The General Structure And Approach Is The Same.

General Structure And Approach To Distribution. Starts With A Certifying Physician Typically A Medical Doctor Or Osteopath Who Is Licensed In Their State. Some States Require Specific Registration Of That Physician As A Certifying Physician.

There Must Exist A Bona Fide Physician-Patient Relationship. Attempt To Prohibit Marijuana Mill Medical Practices: Clinical Visit Required Clinical Visit Must Be In The Usual Course Of His/Her Practice Complete and Document A Full Assessment Including Taking History And Documenting Current Medical Condition Explain The Risks And Benefits Of Marijuana Use Continues To Have A Role In The Ongoing Care/Treatment Of Patient

Certifying Physician Must Make A Determination That The Patient Has A Debilitating Medical Condition. Usually Defined Within Statute/Regulation: Cancer Glaucoma HIV + AIDS Hepatitis C ALS Crohn s Disease Parkinsons MS Chronic Pain Muscle Spasticity Seizure Disorder And Other Debilitating Conditions As Determined By Certifying Physician.

After A Qualifying Physician Determines Patient Has A Debilitation Medical Condition: Patient Must Then Register With The State And Apply For Qualified Patient Status. The State Then Issues A Registration Card Which Is Valid For Varying Periods Of Time, Usually No More Than A Year. Once Registration Completed, Patient Can Then Obtain Marijuana From A Registered Marijuana Dispensary ( RMD ).

The Structure/Framework Of A Dispensary: State Legislatures Had Two Options With Respect To Regulating The Dispensaries: Option #1: Heavily Regulated (i.e.- Methadone Maintenance) Option #2: Industry Self-Regulation

Example Of Heavily Regulated: Methadone Maintenance Treatment: Many States Have Strict Mandates As To The Structure Of These Clinics In Both The Required Staff Positions And Their Specific Responsibilities: Each Center Requires A Medical Director Responsible For Specifically Mandated Tasks And Specific Number Of Hours They Must Be Present To: Oversee Nursing Staff, Promulgate Policies And Procedures, Review Test Results, Staff Training, Chart Reviews, Etc

Example Of Heavily Regulated: Methadone Maintenance Treatment: Many States Have Strict Mandates As To The Substance Of The Actual Services Provided: Mandated Counseling Hours Mandated Drug Testing Mandated Policies/Practices Of Patients Who Fail Drug Testing Or Patients Who Continue To Use Illicit Substances

In Terms Of Exposure For Heavily Regulated Jurisdictions: Creates Very Well Defined And Precise Standards Of Conduct/Care. In Some Jurisdictions, Evidence Of Violation Of Regulation/Statute per se Negligence. The More Numerous And Specific The Statutes/Regulations Are, The More Opportunity For Exposure. Plaintiff s Love Highly Regulated Industries Because The Standard Of Care Is Defined For Them And Can Likely Find Conduct In Any Case Which Does Not Follow The Statute/Regulation Precisely. Juries: Regulations Make The Concept Of Standard Of Care Easier.

In Terms Of Marijuana, Most States Have Chosen To Regulate Heavily Certain Aspects And Not Heavily Regulate Other Aspects: Heavily Regulated Becoming A Licensed Dispensary Becoming A Registered Certifying Physician Becoming A Qualified Patient Less Regulated The Actual Process Of Dispensing Marijuana The Roles And Responsibilities Of The Dispensaries

Statutory/Regulatory Requirements Of Dispensaries Most States Do Not Require Any Specific Assessment Of The Patient. No Illicit Drug Testing No Assessment As To Impairment And Driving No Assessment As To Impairment As Evidence Of Drug Abuse No Assessment As To Whether The Patient Is Having Adverse Side Effects No Assessment As To Whether The Dose Is Appropriate In Fact, Some States Specifically Prohibit The Dispensaries From Giving Advice Or Making Recommendations As To What Marijuana Products They Sell.

Statutory/Regulatory Requirements Of Dispensaries Most States Have Kept The Responsibilities Of The Dispensaries Vague: Example: Connecticut- One Of The Most Regulated States. A Dispensary Shall Exercise Professional Judgment To Determine Whether To Dispense Marijuana To A Qualifying Patient... If The Dispensary Suspects That Dispensing Marijuana To The Qualifying Patient May Have Negative Health Or Safety Consequences For The Qualifying Patient Or The Public.

Statutory/Regulatory Requirements Of Dispensaries Most States Have Kept The Responsibilities Of The Dispensaries Vague: Example: Massachusetts. A RMD [Registered Marijuana Dispensary] May Refuse To Dispense To A Registered Qualifying Patient... If In The Opinion Of The Dispensary Agent, The Patient Or Public Would Be Placed At Risk. (Emphasis Added)

Risk/Liability Implications: The Statutory/Regulatory Scheme Has Direct Impact On Liability Exposure to Dispensaries and Certifying Physicians: Generally Speaking, The Statutory and Regulatory Schemes That Have Been Created Will Likely Shift Liability and Exposure To The Certifying Physicians. More Like Pharmacies, Which Do Not Have Authority To Change Or Alter Prescriptions Made By Physicians. (See infra).

Risk/Liability Implications: Shifting Liability and Exposure To The Certifying Physicians. No Regulatory Responsibility To Assess Patients For Impairment No Regulatory Responsibility To Perform Drug Testing For Other Illicit Substances (i.e.- Those Which May Have Synergistic Effects) No Regulatory Responsibility To Assess Adverse Side Effects/Dosage Effects/Medication Contra-Indications. Extreme Example: Massachusetts. Regulation Requires All Dispensaries To Be Non-Profit. Cap Implications.

Risk/Liability Implications: Whether The Certifying Physician Realizes It Or Not, These Assessments Of Patients Fall On Them. Even More Important, The Failure To Perform These Assessments Will Likely Have Direct Impact On Public Safety And The Safety Of Patients. Example: Polysubstance Abuser Who Becomes A Qualified Patient And Synergistic Effect With Marijuana Impairs Ability To Drive Safely Resulting In Car Accident.

Regulatory/Statutory Framework Of The Medicinal Marijuana System Is Fluid And Evolving. Most States, While They Have Legalized Marijuana, Have Simply Laid Down Some Ground Rules And Ordered (Typically The Health And Human Services Department) To Come Up With Regulations As To How It Will Work. Even After Regulations Are Passed, They Are Likely To Evolve With The Emergence Of (Arguably) Unforeseen Issues.

Legal Bases for Liability Some Potentially Unforeseen Scenarios 1) Is a Dispensary a Pharmacy? Although a pharmacy clearly has the duty to fill prescriptions correctly..we have not addressed the issue whether a pharmacy has a duty to warn its customers of the risks and side effects of the drugs it dispenses. A number of jurisdictions have addressed the issue, and the overwhelming majority hold that, in general, a pharmacy has no duty to warn its customers of side effects. We similarly hold that, generally, a pharmacy has no duty to warn its customers of the side effects of prescription drugs. Cottam v. CVS Pharmacy, 436 Mass. 316, 320-21, 764 N.E.2d 814, 819-20 (2002)

Cites Pennsylvania law approvingly: Coyle v. Richardson-Merrell, Inc., 526 Pa. 208, 584 A.2d 1383 (1991) --notes that there is good reason to treat pharmacies differently from other retailers of commercial products: pharmacists do not choose which products to make available to consumers and patients do not choose which products to buy.. The pharmacist does not have discretion to alter or refuse to fill a prescription because the risks and benefits of that prescription for that particular patient have already been weighed by the physician.

Does the Massachusetts regulatory scheme, which allows a discretionary refusal of dispensing marijuana, take dispensaries out of Cottam? Where does the duty to warn lie? Does that take the physician off the hook?

Unforeseeable third parties? 3 rd party liability narrow rule in Massachusetts: Coombes v. Florio, 450 Mass. 182, 877 N.E.2d 567 (2007) found that a physician owes a limited duty to third parties, foreseeably at risk from a patient's decision to operate a motor vehicle, to warn the patient of the known side effects of medications the physician has prescribed that might impair the patient's ability as a motorist.

Broader rule in states like Indiana? Although physician had no relationship with the other motorist, a third-party victim of driver's conduct, it was reasonably foreseeable that driver, with her medical conditions and under medications prescribed by physician, was at risk of losing consciousness while driving and posed a danger to third persons. Manley v. Sherer, 960 N.E.2d 815 (Ind. Ct. App. 2011).

2014 Vasquez decision in Massachusetts expands third party liability? Vasquez, et al. v. Community Health Care, Inc., Patient receives methadone from clinic methadone with no advisory of any kind regarding the effects of the new dosage which had been increased two days earlier on his ability to safely operate a motor vehicle. He also allegedly had other illicit drugs in his system that morning. Half hour after receiving his dose, he drives and drifts into the another lane Two third parties killed. Estates sue, alleging that the clinic was negligent in its care and treatment of patient, which proximately causing their injuries and deaths. Clinic moves for summary judgment, on grounds that, among other things, its duty of reasonable care did not extend to non-patient third parties. Here, as in Coombes, liability would be based on the act of prescribing a drug with known side effects that could foreseeably endanger the public. and requires nothing from a doctor that is not already required.

Synergistic Effects of Drug Interactions In cases with methadone dispensaries, regular fact pattern involves a car crash, with an allegation that the clinic staff failed to properly monitor a patient s pattern of multidrug intake. With a patient who shows positives in benzodiazipines or marijuana, claim is that the clinic should have ceased providing or more strongly warned of synergistic effects of the drugs.

Typical expert affidavit: Combining methadone with benzodiazepines and marijuana can cause serious and potentially dangerous side effects... These side effects include, but are not limited to, poor concentration, drowsiness and sedation. The combination of methadone with benzodiazepines and marijuana can greatly impair the mental and/or physical abilities required for the safe performance of potentially hazardous tasks, such as driving a car... A reasonably foreseeable consequence of an individual operating a motor vehicle while combining methadone with benzodiazepines and marijuana is that a vehicle accident may occur and other persons may be injured. A medical director of a methadone clinic should have knowledge of this. Taylor v. Smith, 892 So. 2d 887, 892 (Ala. 2004)

Risks to Physician-Prescribers? Where there has been limited research on potential interactions (based on federal preclusions), how does the physician make a determination as to potential synergistic effects? Does the physician have to evaluate all potential interactions before prescribing? How? Is it like any other drug? Is it in the PDR?

Learned Intermediary doctrine? What happens? Manufacturers of drugs duty to warn extends to physicians as the learned intermediary. What happens when no information is forwarded about risks? Who is the learned intermediary in medical marijuana cases?

Violation of federal regulatory authority relative to drugs in conflict with federal law? Controlled Substances Act (CSA) Even if not enforced? Negligence per se/evidence of Negligence?

Much is made of claim that Federal authorities will not enforce CSA as to marijuana.

Take Away Points Although MM Has Been Legalized In Many States, The Process Of How This Will Occur Is Still A Work In Progress. However, It Appears That Most States Have Chosen A Pharmacy Approach To Dispensaries. What This Means Is That Liability Exposure Is Likely To Fall On The Certifying Physicians. The Greatest Exposure Will Likely Be Automobile Accidents.